Evidence map›Paper›PMID 33637972›Full record

ArticleCell death and differentiation2021

Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade.

Wei Wang, Taiqiang Yan, Wei Guo, Jianfang Niu, Zhiqing Zhao, Kunkun Sun, Hongliang Zhang, Yiyang Yu, Tingting Ren

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.Journal of cancer research and clinical oncology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Wei WangMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.ORCID http://orcid.org/0000-0003-3426-3311
Taiqiang YanMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China. yantqzh@163.com.ORCID http://orcid.org/0000-0003-3982-1052
Wei GuoMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China. bonetumor@163.com.ORCID http://orcid.org/0000-0003-2471-5767
Jianfang NiuMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Zhiqing ZhaoMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Kunkun SunDepartment of Pathology, Peking University People's Hospital, Beijing, China.
Hongliang ZhangMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Yiyang YuMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Tingting RenMusculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Peking University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81572635National Natural Science Foundation of China (National Science Foundation of China) 81972513
6 · The paper itself

Abstract

Hedgehog signaling plays a pivotal role in embryonic pattern formation and diverse aspects of the postnatal biological process. Perturbation of the hedgehog pathway and overexpression of GLI1, a downstream transcription factor in the hedgehog pathway, are highly relevant to several malignancies including chondrosarcoma (CS). We previously found that knocking down expression of GLI1 attenuates the disrupted Indian hedgehog (IHH) signal pathway and suppresses cell survival in human CS cells. However, the underlying mechanisms regulating the expression of GLI1 are still unknown. Here, we demonstrated the implication of GLI1 in SMO-independent pathways in CS cells. A GLI1 binding protein, major vault protein (MVP), was identified using the affinity purification method. MVP promoted the nuclear transport and stabilization of GLI1 by compromising the binding affinity of GLI1 with suppressor of fused homolog (SUFU) and increased GLI1 expression via mTOR/S6K1 signaling cascade. Functionally, knockdown of MVP suppressed cell growth and induced apoptosis. Simultaneous inhibition of MVP and GLI1 strongly inhibits the growth of CS in vitro and in vivo. Moreover, IHC results showed that MVP, GLI1, and P-p70S6K1 were highly expressed and positively correlated with each other in 71 human CS tissues. Overall, our findings revealed a novel regulating mechanism for HH-independent GLI1 expression and provide a rationale for combination therapy in patients with advanced CS.

Indexed as

AnimalsBone NeoplasmsCell Line, TumorCell ProliferationChondrosarcomaFemaleGene Expression Regulation, NeoplasticHedgehog ProteinsHumansMajor Vault ProteinMiceMice, Inbred BALB CMice, NudeRibosomal Protein S6 Kinases, 70-kDaSignal TransductionTOR Serine-Threonine KinasesGLI1 protein, humanHedgehog ProteinsMajor Vault Proteinribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaTOR Serine-Threonine KinasesVault Ribonucleoprotein ParticlesZinc Finger Protein GLI1

Identifiers

PMID33637972
PMCPMC8257592
OpenAlexW3132907914

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.